Log In
Print this Print this

Intranasal fluticasone propionate (OPN-375)

  Manage Alerts
Collapse Summary General Information
Company OptiNose Inc.
DescriptionIntranasal fluticasone delivered using the OptiNose bidirectional nasal delivery device
Molecular Target Glucocorticoid receptor (GCCR)
Mechanism of Action 
Therapeutic ModalityMedical Devices: Drug/device combination
Latest Stage of DevelopmentPhase III
Standard Indication Inflammation (unspecified)
Indication DetailsReduce or eliminate nasal polyps in patients with chronic rhinosinusitis; Treat chronic rhinosinusitis with or without nasal polyps; Treat nasal polyps; Treat refractory chronic rhinosinusitis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today